Copyright Reports & Markets. All rights reserved.

Global CRISPR-PE Technology Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global CRISPR-PE Technology Market Size 2016-2026
    • 2.1.2 CRISPR-PE Technology Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 CRISPR-PE Technology Segment by Type
    • 2.2.1 Cell Line Engineering
    • 2.2.2 Cell Line Engineering
  • 2.3 CRISPR-PE Technology Market Size by Type
    • 2.3.1 Global CRISPR-PE Technology Market Size CAGR by Type
    • 2.3.2 Global CRISPR-PE Technology Market Size Market Share by Type (2016-2021)
  • 2.4 CRISPR-PE Technology Segment by Application
    • 2.4.1 Biomedical Research
    • 2.4.2 Agricultural Research
    • 2.4.3 Others
  • 2.5 CRISPR-PE Technology Market Size by Application
    • 2.5.1 Global CRISPR-PE Technology Market Size CAGR by Application
    • 2.5.2 Global CRISPR-PE Technology Market Size Market Share by Application (2016-2021)

3 CRISPR-PE Technology Market Size by Players

  • 3.1 CRISPR-PE Technology Market Size Market Share by Players
    • 3.1.1 Global CRISPR-PE Technology Revenue by Players (2019-2021E)
    • 3.1.2 Global CRISPR-PE Technology Revenue Market Share by Players (2019-2021E)
  • 3.2 Global CRISPR-PE Technology Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 CRISPR-PE Technology by Regions

  • 4.1 CRISPR-PE Technology Market Size by Regions (2016-2021)
  • 4.2 Americas CRISPR-PE Technology Market Size Growth (2016-2021)
  • 4.3 APAC CRISPR-PE Technology Market Size Growth (2016-2021)
  • 4.4 Europe CRISPR-PE Technology Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa CRISPR-PE Technology Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas CRISPR-PE Technology Market Size by Country (2016-2021)
  • 5.2 Americas CRISPR-PE Technology Market Size by Type (2016-2021)
  • 5.3 Americas CRISPR-PE Technology Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC CRISPR-PE Technology Market Size by Region (2016-2021)
  • 6.2 APAC CRISPR-PE Technology Market Size by Type (2016-2021)
  • 6.3 APAC CRISPR-PE Technology Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe CRISPR-PE Technology by Country (2016-2021)
  • 7.2 Europe CRISPR-PE Technology Market Size by Type (2016-2021)
  • 7.3 Europe CRISPR-PE Technology Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa CRISPR-PE Technology by Region (2016-2021)
  • 8.2 Middle East & Africa CRISPR-PE Technology Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa CRISPR-PE Technology Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global CRISPR-PE Technology Market Forecast

  • 10.1 Global CRISPR-PE Technology Forecast by Regions (2021-2026)
    • 10.1.1 Global CRISPR-PE Technology Forecast by Regions (2021-2026)
    • 10.1.2 Americas CRISPR-PE Technology Forecast
    • 10.1.3 APAC CRISPR-PE Technology Forecast
    • 10.1.4 Europe CRISPR-PE Technology Forecast
    • 10.1.5 Middle East & Africa CRISPR-PE Technology Forecast
  • 10.2 Americas CRISPR-PE Technology Forecast by Countries (2021-2026)
    • 10.2.1 United States CRISPR-PE Technology Market Forecast
    • 10.2.2 Canada CRISPR-PE Technology Market Forecast
    • 10.2.3 Mexico CRISPR-PE Technology Market Forecast
    • 10.2.4 Brazil CRISPR-PE Technology Market Forecast
  • 10.3 APAC CRISPR-PE Technology Forecast by Region (2021-2026)
    • 10.3.1 China CRISPR-PE Technology Market Forecast
    • 10.3.2 Japan CRISPR-PE Technology Market Forecast
    • 10.3.3 Korea CRISPR-PE Technology Market Forecast
    • 10.3.4 Southeast Asia CRISPR-PE Technology Market Forecast
    • 10.3.5 India CRISPR-PE Technology Market Forecast
    • 10.3.6 Australia CRISPR-PE Technology Market Forecast
  • 10.4 Europe CRISPR-PE Technology Forecast by Country (2021-2026)
    • 10.4.1 Germany CRISPR-PE Technology Market Forecast
    • 10.4.2 France CRISPR-PE Technology Market Forecast
    • 10.4.3 UK CRISPR-PE Technology Market Forecast
    • 10.4.4 Italy CRISPR-PE Technology Market Forecast
    • 10.4.5 Russia CRISPR-PE Technology Market Forecast
  • 10.5 Middle East & Africa CRISPR-PE Technology Forecast by Region (2021-2026)
    • 10.5.1 Egypt CRISPR-PE Technology Market Forecast
    • 10.5.2 South Africa CRISPR-PE Technology Market Forecast
    • 10.5.3 Israel CRISPR-PE Technology Market Forecast
    • 10.5.4 Turkey CRISPR-PE Technology Market Forecast
    • 10.5.5 GCC Countries CRISPR-PE Technology Market Forecast
  • 10.6 Global CRISPR-PE Technology Forecast by Type (2021-2026)
  • 10.7 Global CRISPR-PE Technology Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Beam Therapeutics
    • 11.1.1 Beam Therapeutics Company Information
    • 11.1.2 Beam Therapeutics CRISPR-PE Technology Product Offered
    • 11.1.3 Beam Therapeutics CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Beam Therapeutics Main Business Overview
    • 11.1.5 Beam Therapeutics Latest Developments
  • 11.2 CRISPR Therapeutics
    • 11.2.1 CRISPR Therapeutics Company Information
    • 11.2.2 CRISPR Therapeutics CRISPR-PE Technology Product Offered
    • 11.2.3 CRISPR Therapeutics CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 CRISPR Therapeutics Main Business Overview
    • 11.2.5 CRISPR Therapeutics Latest Developments
  • 11.3 GenScript Biotech
    • 11.3.1 GenScript Biotech Company Information
    • 11.3.2 GenScript Biotech CRISPR-PE Technology Product Offered
    • 11.3.3 GenScript Biotech CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 GenScript Biotech Main Business Overview
    • 11.3.5 GenScript Biotech Latest Developments
  • 11.4 Horizon Discovery
    • 11.4.1 Horizon Discovery Company Information
    • 11.4.2 Horizon Discovery CRISPR-PE Technology Product Offered
    • 11.4.3 Horizon Discovery CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Horizon Discovery Main Business Overview
    • 11.4.5 Horizon Discovery Latest Developments
  • 11.5 Integrated DNA Technologies (IDT
    • 11.5.1 Integrated DNA Technologies (IDT Company Information
    • 11.5.2 Integrated DNA Technologies (IDT CRISPR-PE Technology Product Offered
    • 11.5.3 Integrated DNA Technologies (IDT CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Integrated DNA Technologies (IDT Main Business Overview
    • 11.5.5 Integrated DNA Technologies (IDT Latest Developments
  • 11.6 Intellia Therapeutics Inc.
    • 11.6.1 Intellia Therapeutics Inc. Company Information
    • 11.6.2 Intellia Therapeutics Inc. CRISPR-PE Technology Product Offered
    • 11.6.3 Intellia Therapeutics Inc. CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Intellia Therapeutics Inc. Main Business Overview
    • 11.6.5 Intellia Therapeutics Inc. Latest Developments
  • 11.7 Inscripta
    • 11.7.1 Inscripta Company Information
    • 11.7.2 Inscripta CRISPR-PE Technology Product Offered
    • 11.7.3 Inscripta CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Inscripta Main Business Overview
    • 11.7.5 Inscripta Latest Developments
  • 11.8 Precision Bioscience
    • 11.8.1 Precision Bioscience Company Information
    • 11.8.2 Precision Bioscience CRISPR-PE Technology Product Offered
    • 11.8.3 Precision Bioscience CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Precision Bioscience Main Business Overview
    • 11.8.5 Precision Bioscience Latest Developments
  • 11.9 Sangoma Therapeutics
    • 11.9.1 Sangoma Therapeutics Company Information
    • 11.9.2 Sangoma Therapeutics CRISPR-PE Technology Product Offered
    • 11.9.3 Sangoma Therapeutics CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Sangoma Therapeutics Main Business Overview
    • 11.9.5 Sangoma Therapeutics Latest Developments
  • 11.10 Synthego Corporation
    • 11.10.1 Synthego Corporation Company Information
    • 11.10.2 Synthego Corporation CRISPR-PE Technology Product Offered
    • 11.10.3 Synthego Corporation CRISPR-PE Technology Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 Synthego Corporation Main Business Overview
    • 11.10.5 Synthego Corporation Latest Developments

12 Research Findings and Conclusion

According to this latest study, the 2021 growth of CRISPR-PE Technology will have significant change from previous year. By the most conservative estimates of global CRISPR-PE Technology market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the CRISPR-PE Technology market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR-PE Technology market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Cell Line Engineering
Genome Regulation

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Biomedical Research
Agricultural Research
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Beam Therapeutics
CRISPR Therapeutics
GenScript Biotech
Horizon Discovery
Integrated DNA Technologies (IDT
Intellia Therapeutics Inc.
Inscripta
Precision Bioscience
Sangoma Therapeutics
Synthego Corporation
Buy now